KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.
Mark R Warner (Senate) disclosed 1 transaction
· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk
2021-06-16 · buy
Acumen Pharmaceuticals, Inc. Company: Acumen Pharmaceuticals, Inc. (San Francisco, CA) Description: Drug Discovery — $15,001 - $50,000
The complete record
Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.
id
senate-68e2d163-9ecd-4bde-a0f2-4b0e2ad08c79-1
owner
Self
party
Democrat
state
VA
office
Warner, Mark R (Senator)
ptr id
68e2d163-9ecd-4bde-a0f2-4b0e2ad08c79
ticker
—
chamber
senate
comment
As of 7/1/21, Acumen Pharmaceuticals, Inc. is a publicly traded stock, ticker symbol (ABOS).
amount max
50000
amount min
15001
asset name
Acumen Pharmaceuticals, Inc. Company: Acumen Pharmaceuticals, Inc. (San Francisco, CA) Description: Drug Discovery
